Development and Dissemination of Evidence-Based Clinical Care Guidelines for Muscular Dystrophies

Post Date

April 15th 2010

Application Due Date

June 15th 2010

Funding Opportunity Number

CDC-RFA-DD10-1012

CFDA Number(s)

93.184

Funding Instrument Type(s)

Grant

Funding Activity Categories

Health

Number of Awards

1

Eligibility Categories

Other

Nonprofit with 501C3 IRS status (other than institution of higher education) Nonprofit without 501C3 IRS status (other than institution of higher education) For-profit organizations (other than small business) Small, minority, and women-owned businesses Universities Colleges Research institutions Hospitals Community-based organizations Faith-based organizations Federally recognized or state-recognized American Indian/Alaska Native tribal governments American Indian/Alaska native tribally designated organizations Alaska Native health corporations Urban Indian health organizations Tribal epidemiology centers State and local governments or their Bona Fide Agents (this includes the District of Columbia, the Commonwealth of Puerto Rico, the Virgin Islands, the Commonwealth of the Northern Marianna Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau) Political subdivisions of States (in consultation with States) A Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local government, a letter from the state or local government as documentation of the status is required.

Funding

• Estimated Total Funding:

  $1050000

• Award Range:

  $0 - $350000

Grant Description

The purpose of this program is to develop evidence-based clinical care guidelines to support clinical decision-making involving the prevention, diagnosis, treatment, and prognosis for individuals who have MD. Specifically, four sets of evidence-based guidelines will be developed based on the best evidence available for the following MDs: myotonic, limb-girdle, facioscapulohumeral, and congenital.

Contact Information

• Agency

  Department of Health and Human Services

• Office:

  Centers for Disease Control and Prevention

• Agency Contact:

  CDC Procurement and Grants Office
  grants
  Phone 770-488-2700

• Agency Mailing Address:

  pgotim@cdc.gov

• Agency Email Address:

  pgotim@cdc.gov